LTFS
OTLK icon

Ladenburg Thalmann Financial Services’s Outlook Therapeutics OTLK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$26K Buy
2,202
+1,398
+174% +$32.5K ﹤0.01% 3983
2019
Q3 		$24K Buy
804
+653
+432% +$25.2K ﹤0.01% 3927
2019
Q2 		$6K Buy
151
+126
+504% +$5.87K ﹤0.01% 4648
2019
Q1 		$4K Buy
+25
New +$3.53K ﹤0.01% 4749

Other funds holding OTLK

LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ladenburg Thalmann Financial Services's OTLK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Outlook Therapeutics (OTLK) stake by 174% in Q4 2019, buying an estimated $32.5K and bringing the position to 2,202 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

Ladenburg Thalmann Financial Services first reported a position in OTLK in Q1 2019 and has held it in 4 quarters since. 17 funds tracked by Wall St. Rank hold OTLK as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2,202 shares of Outlook Therapeutics worth $26K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 1,398 Outlook Therapeutics shares in Q4 2019, an estimated $32.5K.
  • Outlook Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3983 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Outlook Therapeutics in Q1 2019 and has held it in 4 quarters since.
  • 17 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.